Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Sable Therapeutics Announces Licensing Agreement with Shanghai Liuqiang Medical Technology
Sable Therapeutics, an early-stage biotechnology company developing novel therapies for fat reduction, today announced that […]
Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology
Aldena Therapeutics, a private biotech company pioneering siRNA-based therapies for dermatological indications, and Empa, the […]
Huma and UCB to Provide Digital Health Solution for Myasthenia Gravis
Huma Therapeutics, a leading global digital health company, and UCB, a global biopharmaceutical company, are […]
Alentis Therapeutics Reports Positive Topline Results From Phase 1 Multiple-ascending Dose Cohorts Study
Alentis Therapeutics, the clinical-stage biotechnology company developing breakthrough treatments for organ fibrosis and CLDN1+ tumors, […]
Biomind Labs Announces the Start of the First-Ever Clinical Trial Targeting Depression and Anxiety in Alzheimer’s Disease
Biomind Labs, a leading biotech company focused on developing the next generation of pharmaceuticals to […]
RQM+ Appoints Steven Pilewski as Lab Services Chief Operating Officer
RQM+, the world’s leading MedTech service provider, has announced the appointment of Steven Pilewski as […]
Mezzion Pharma Raises Nearly $40M to Advance a First-to-Market Treatment Option for Fontan Patients
Mezzion Pharma, a rare disease-focused pharmaceutical company, announced that it has secured nearly $40M USD […]
n-Lorem Foundation Awarded Prestigious 2023 Edison Award
n-Lorem, a nonprofit Foundation, today announced that it has been selected as a 2023 Edison […]
National Multicenter Trial Opens to Study ImmunityBio’s Tri-Ad5 Cancer Vaccines Plus N-803 to Prevent Cancer in People with Lynch Syndrome
ImmunityBio, a clinical-stage immunotherapy company, today announced the opening of a clinical trial to study […]
Ventoux Biosciences Launches to Transform Disease Management for Fibrotic Disease
Ventoux Biosciences, a privately held specialty pharmaceutical company, has launched with a mission to deliver […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more